STACKDSTACKDResearch
Sign up

Compound library

Peptides

Deep profiles for diligence, not product pages. Filter by goal or open any profile for mechanism, evidence, and citations.

45 compounds catalogued

Filter by goal

Showing 15 peptides tagged Recovery.

BPC-157

Emerging

A synthetic peptide fragment derived from a gastric protein, widely discussed for soft-tissue recovery. Human evidence remains limited relative to its online popularity.

Recovery · Skin / repair · Gut health

TB-500

Emerging

A synthetic peptide associated with thymosin beta-4 research, commonly discussed alongside soft-tissue recovery and mobility. Often paired conversationally with BPC-157.

Recovery · Skin / repair

CJC-1295

Limited human data

A growth hormone-releasing hormone (GHRH) analogue discussed for GH-axis support. Often mentioned with ipamorelin in fitness forums as a commonly discussed pairing.

Muscle / GH axis · Recovery · Sleep / recovery adjunct

Ipamorelin

Limited human data

A selective growth hormone secretagogue (ghrelin-receptor agonist) discussed for GH pulses with a relatively favorable selectivity profile in older literature.

Muscle / GH axis · Recovery · Sleep / recovery adjunct

MOTS-c

Emerging

A mitochondria-derived peptide researched for metabolic regulation and exercise-related stress responses. Still early relative to incretin drugs, but frequently searched in biohacking circles.

Metabolic · Fat loss · Recovery · Longevity / aging

GHK-Cu

Limited human data

A copper-binding tripeptide studied in skin biology and remodeling. Appears in topical cosmetic research and in online discussions of recovery and tissue quality.

Skin / repair · Recovery

Hexarelin

Limited human data

A synthetic hexapeptide growth hormone secretagogue that activates the ghrelin receptor, producing one of the strongest GH releases of any peptide in its class. Distinct among GH secretagogues for a separate, GH-independent cardioprotective effect documented in animal models.

Muscle / GH axis · Recovery

GHRP-2

Limited human data

A synthetic hexapeptide ghrelin receptor agonist that stimulates growth hormone release. Notable for being the one compound in this family with a real regulatory approval, marketed in Japan as a diagnostic agent for GH deficiency under the name pralmorelin.

Muscle / GH axis · Recovery

GHRP-6

Limited human data

The original growth hormone-releasing hexapeptide, discovered in 1984 and the founding compound of the entire GHRP family, including GHRP-2 and hexarelin. Known for producing the strongest appetite stimulation of the group alongside its GH-releasing effect.

Muscle / GH axis · Recovery

SS-31 (Elamipretide)

Stronger clinical signal

A mitochondria-targeted peptide that stabilizes cardiolipin in the inner mitochondrial membrane, supporting energy production and reducing oxidative stress. FDA-approved as elamipretide for Barth syndrome, a rare genetic mitochondrial disease, and one of the few peptides in this category with an actual regulatory approval.

Longevity / aging · Recovery

A naturally occurring protein that neutralizes myostatin and related growth-inhibiting signals, allowing muscle to grow beyond its normal ceiling. The systemically circulating isoform used in early-phase gene therapy trials for muscular dystrophy, now also sold as a standalone research peptide with no human data in that injectable form.

Muscle / GH axis · Recovery

A splice variant of IGF-1 that muscle tissue produces locally in response to mechanical stretch, stimulation, or injury. Studied mainly in animal and cell models of muscle repair and regeneration; sold as a synthetic research peptide despite very limited direct human data.

Muscle / GH axis · Recovery

PEG-MGF

Emerging

A polyethylene glycol-modified version of MGF designed to extend the parent peptide's minutes-long half-life to several days. A research-chemical product built on real underlying biology, but with essentially no dedicated studies of its own, pegylated form.

Muscle / GH axis · Recovery

ARA-290 (Cibinetide)

Limited human data

An 11-amino-acid peptide engineered from a non-erythropoietic region of erythropoietin, designed to activate tissue-repair signaling without stimulating red blood cell production. Studied in phase 2 human trials for small-fiber neuropathy, one of the more clinically tested "tissue protective" peptides.

Recovery · Neuroprotection

Epitalon

Emerging

A synthetic tetrapeptide associated with pineal peptide research and aging biology conversations. Evidence is largely historical/preclinical with limited modern RCT coverage.

Longevity / aging · Sleep / recovery adjunct · Recovery

Evidence labels

  • EmergingMostly preclinical or early signals; human athletic data is thin.
  • Limited human dataSome human pharmacology or small studies; outcomes for fitness use remain limited.
  • Stronger clinical signalSupported by larger clinical trials in defined medical populations.

Anodized by evidence strength: blue = stronger clinical/human data, violet = limited human data or mechanism, steel = emerging/anecdotal, and amber = an in-house STACKD summary.